Short-term memory loss can be a sign of early-stage Alzheimer's disease. It can manifest as difficulty creating new memories or problems retrieving them. For example, someone with early Alzheimer's ...

Hilary Evans-Newton is the Chief Executive of Alzheimer’s Research UK. Hilary joined Alzheimer’s Research UK in 2013 and has overseen significant growth in income in recent years, which has ...

Brain inflammation, while a crucial part of the body's immune response, takes on a detrimental role in Alzheimer's disease. Unlike the acute, short-lived inflammation that combats infection, the ...

Irene Mekel, who seeks medical assistance in dying, was diagnosed with Alzheimer’s disease a year ago.Credit...Melissa Schriek for The New York Times Supported by By Stephanie Nolen Stephanie ...

An inert and unreactive gas may not seem like an obvious candidate for treating Alzheimer’s disease, yet a new study in mice suggests that xenon might just be the breakthrough we need. Xenon is one of ...

--(BUSINESS WIRE)--Netris, an innovative software company specializing in cloud-like network automation and abstraction, is excited to announce a partnership with XENON Systems, a premier high ...

Xenon bulbs, or HID (High-Intensity Discharge) bulbs, have been responsible for changing the face of car fronts as an alternative to traditional halogen headlight bulbs. You might think that Xenon ...

Rivastigmine is a drug that may help people with Alzheimer’s disease improve thinking, memory, communication, and how they perform activities. It is a daily patch people wear on the skin.